glp 1 fgf21 agonist boehringer Targeting GLP-1, GIP & GCG in Obesity and Type 2 Diabetes Research Alimentary Pharmacology & Therapeutics |

GLP-1 Pipeline Update: November 2025 Quarterly view of the GLP-1 pipeline and anticipated indications Editorial team Maryam Tabatabai, PharmD Editor-In-Chief Associate Vice President, Clinical Information Carole Kerzic, RPh Executive Editor Drug Information Pharmacist Principal Nicole Kjesbo, PharmD, BCPS Executive Editor Clinical Program Development Director Senior, Pipeline DISCLAIMER The drug pipeline is fluid

Co-authors include Jennifer Hwang, DO, Neda Laiteerapong, MD, Elbert Huang, MD and David D

Under the deal, $1.65B was paid immediately and further milestones could bring the total cost to $5.3B ( [13] )

2021;274(6):e126976

Around 3,000 lawsuits have been filed in MDL 3094 in the Eastern District of Pennsylvania alleging gastrointestinal injuries and vision loss linked to Ozempic and similar medications

How Often